Obstructive Sleep Apnea and Comprehensive Remotely-supervised Rehabilitation Program
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Other: Remotely-supervised rehabilitation program
- Registration Number
- NCT04759456
- Lead Sponsor
- Brno University Hospital
- Brief Summary
The purpose of this study is to investigate the feasibility and effect of a 12-week remotely-supervised rehabilitation program in male patients between 25-65 years old with newly diagnosed obstructive sleep apnea with Apnea-Hypopnea Index greater than 15 episodes per hour indicated to CPAP therapy.
- Detailed Description
The intervention group will undergo comprehensive remotely-supervised rehabilitaiton program in home conditions with teleconsultation (contains telecoaching, telemonitoring) via regular phone calls and e-mails at least 2 times a week. The intervention will include nutrition, health-related lifestyle and behavioral changes recommendations, and at least 5 times a week 30 minutes of moderate-intensity aerobic training, 10 minutes of inspiratory and expiratory muscle training with breathing device and 10 minutes of oropharyngeal exercise along with individually titrated CPAP therapy.
The control group will undergo individually titrated CPAP therapy only. The participants in both groups will go through the following assessments before and after this study: polysomnography, spirometry, anthropometry and body composition examination, laboratory values examination, quality of life questionnaires, Epworth sleepiness scale, 6-min walking test.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Male
- Target Recruitment
- 50
- signed informed consent
- newly diagnosed obstructive sleep apnea
- Apnea-Hypopnea Index greater than 15 episodes/hour
- indicated for CPAP therapy
- severe pulmonary hypertension
- severe heart valve disease
- COPD III or IV
- central sleep apnea
- chronic corticosteroid therapy
- long-term oxygen therapy
- heart failure
- left ventricular ejection fraction lower than 40 %
- NYHA III or IV
- cerebrovascular disease
- psychiatric disease
- another type of obstructive sleep apnea treatment
- acute coronary syndrome in anamnesis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention group Remotely-supervised rehabilitation program Participants will undergo 12-week comprehensive remotely-supervised rehabilitation program along with individually titrated CPAP therapy.
- Primary Outcome Measures
Name Time Method Change from Baseline in Apnea-Hypopnea Index at Week 12 Baseline and Week 12 Measure will be taken from Polysomnography. Index shows number of apneic or hypopneic periods with duration at least 5 seconds in one hour. Higher Index means worse outcome.
Change from Baseline in SF-36 Questionnaire Score at Week 12 Baseline and Week 12 SF-36 Score is validated, self-reported instrument of patient's perception of health state and quality of life. Possible scores range is from 0 to 100 points. Higher score means better outcome.
Changes from Baseline in Body composition at Week 12 Baseline and Week 12 Measure will be taken from InBody 370.
Change from Baseline in 6 Minutes Walking Test at Week 12 Baseline and Week 12 6MWT will be evaluated on flat 30 metres long track marked with two cones. Longer distance means better outcome.
Change from Baseline in Epworth Sleepiness Scale Score at Week 12 Baseline and Week 12 ESS Score is validated, self-reported instrument of patient's perception of obstructive sleep apnea. Possible scores range is from 0 to 24 points. Higher score means worse outcome.
Change from Baseline in Maximal Inspiratory Pressure at Week 12 Baseline and Week 12 Participants will make 3-5 attempts with 1 minute pause between them. Noted will be the highest score. Higher score means better outcome.
Change from Baseline in Maximal Expiratory Pressure at Week 12 Baseline and Week 12 Participants will make 3-5 attempts with 1 minute pause between them. Noted will be the highest score. Higher score means better outcome.
- Secondary Outcome Measures
Name Time Method Change from Baseline in Forced Vital Capacity at Week 12 Baseline and Week 12 Measure will be taken from Spirometry.
Change from Baseline in Neck/Waist/Hip circumferences at Week 12 Baseline and Week 12 All circumferences will be measured by tape measure.
Change from Baseline in Forced Expiratory Volume in 1 Second at Week 12 Baseline and Week 12 Measure will be taken from Spirometry.
Change from Baseline in Oxygen Desaturation Index at Week 12 Baseline and Week 12 Measure will be taken from Polysomnography. ODI means number of times per hour of sleep that the blood's oxygen level drop by a certain degree from baseline.
Change from Baseline in Body Mass Index at Week 12 Baseline and Week 12 BMI will be calculated of participant's current weight and height.
Trial Locations
- Locations (1)
University Hospital Brno
🇨🇿Brno, Czechia